BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31888533)

  • 21. Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality.
    Siew ED; Parr SK; Abdel-Kader K; Perkins AM; Greevy RA; Vincz AJ; Denton J; Wilson OD; Hung AM; Ikizler TA; Robinson-Cohen C; Matheny ME
    Kidney Int; 2021 May; 99(5):1202-1212. PubMed ID: 32916177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza.
    Birkelo BC; Parr SK; Perkins AM; Greevy RA; Arroyo JP; Hung AM; Vincz AJ; Shah SC; Kapoor T; Matheny ME; Siew ED
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):423-425. PubMed ID: 35110376
    [No Abstract]   [Full Text] [Related]  

  • 23. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
    Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J; Kimmel PL; Parikh CR; Siew ED; Ware LB; Zeng H; Hsu CY; ;
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):26-36. PubMed ID: 33272913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.
    Lee SA; Park R; Yang JH; Min IK; Park JT; Han SH; Kang SW; Yoo TH
    Sci Rep; 2021 Jun; 11(1):13588. PubMed ID: 34193877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
    JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.
    Kunitsu Y; Hira D; Morikochi A; Ueda T; Isono T; Morita SY; Terada T
    PLoS One; 2022; 17(2):e0263682. PubMed ID: 35139129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate and Outcome of Acute Kidney Injury Following Hip Fracture Surgery in Diabetic Older Patients Treated with Renin-Angiotensin-Aldosterone Antagonists.
    Frenkel Rutenberg T; Bdeir A; Rozen-Zvi B; Rosenthal Y; Velkes S; Weiss A; Beloosesky Y
    Drugs Aging; 2019 Jul; 36(7):667-674. PubMed ID: 30949984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis.
    Whiting P; Morden A; Tomlinson LA; Caskey F; Blakeman T; Tomson C; Stone T; Richards A; Savović J; Horwood J
    BMJ Open; 2017 Apr; 7(4):e012674. PubMed ID: 28389482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database.
    Iwagami M; Mansfield K; Quint J; Nitsch D; Tomlinson L
    BMC Pulm Med; 2016 Jan; 16():14. PubMed ID: 26787372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
    Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute kidney injury post-major orthopaedic surgery: A single-Centre case-control study.
    Ying T; Chan S; Lane S; Somerville C
    Nephrology (Carlton); 2018 Feb; 23(2):126-132. PubMed ID: 27706879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined blockade of renin-angiotensin-aldosterone system reduced all-cause but not cardiovascular mortality in dialysis patients: A mediation analysis and systematic review.
    Li SM; He WB; Chen J; Cai QQ; Huang FF; Zhang K; Wang JF; Liu X; Huang H
    Atherosclerosis; 2018 Feb; 269():35-41. PubMed ID: 29258005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.
    Carbone LD; Vasan S; Prentice RL; Harshfield G; Haring B; Cauley JA; Johnson KC
    Osteoporos Int; 2019 Oct; 30(10):2039-2056. PubMed ID: 31209511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors.
    Mark PB; Papworth R; Ramparsad N; Tomlinson LA; Sawhney S; Black C; McConnachie A; McCowan C
    Br J Clin Pharmacol; 2020 Jan; 86(1):121-131. PubMed ID: 31663151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)].
    Santoro A; Mandreoli M
    G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.
    Lapi F; Azoulay L; Yin H; Nessim SJ; Suissa S
    BMJ; 2013 Jan; 346():e8525. PubMed ID: 23299844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.
    Faber SJ; Scherpbier ND; Peters HJG; Uijen AA
    BMC Nephrol; 2019 Dec; 20(1):449. PubMed ID: 31801476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
    BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.